Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass.
Konstantin KazankovKirstine Nyvold Bojsen-MøllerHolger Jon MøllerSten MadsbadHenning GrønbaekPublished in: Physiological reports (2022)
Macrophage activation is associated with liver injury and hepatic IS in obese patients. Improvements in these measures correlate during the first 3 months following RYGB, supporting a link between macrophages and hepatic IS in severe obesity and diabetes.